A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection
PHASE3
To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Status
Not Yet Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer
PHASE2
This study intends to enroll gastric cancer patients who are PD-L1 positive...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University